RBC Bioscience (ROCO:6848) Ending Cash Position : NT$65.2 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Ending Cash Position?

RBC Bioscience's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$65.2 Mil.

RBC Bioscience's quarterly Ending Cash Position declined from Dec. 2022 (NT$75.9 Mil) to Jun. 2023 (NT$66.1 Mil) and declined from Jun. 2023 (NT$66.1 Mil) to Dec. 2023 (NT$65.2 Mil).

RBC Bioscience's annual Ending Cash Position declined from Dec. 2021 (NT$97.5 Mil) to Dec. 2022 (NT$75.9 Mil) and declined from Dec. 2022 (NT$75.9 Mil) to Dec. 2023 (NT$65.2 Mil).

RBC Bioscience Ending Cash Position Historical Data

The historical data trend for RBC Bioscience's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Ending Cash Position Chart

RBC Bioscience Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

43.26

123.94

97.47

75.93

65.18

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial					97.47	93.83	75.93	66.14	65.18

RBC Bioscience Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

RBC Bioscience's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	75.928	+	-10.751
	=	65.2

RBC Bioscience's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	66.141	+	-0.964
	=	65.2

RBC Bioscience Ending Cash Position Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145

Website

https://www.rbcbioscience.com

RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines